Dr. Worth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd Unit 87
Houston, TX 77030Phone+1 713-792-7751Fax+1 713-794-5042
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1998
- University of Texas Health Science Center at HoustonResidency, Pediatrics, 1990 - 1994
- McGovern Medical School at UTHealthClass of 1990
Certifications & Licensure
- TX State Medical License 1991 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Start of enrollment: 2005 Oct 01
- Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma Start of enrollment: 2007 Oct 01
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies Start of enrollment: 2009 Mar 02
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsOutcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-T...Ossama M. Maher, Jorge Galvez Silva, Jimin Wu, Diane Liu, Laurence J.N. Cooper
Pediatric Transplantation. 2017-05-01 - 78 citationsTreatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear CellsCharles S. Cox, Robert A. Hetz, George P. Liao, Benjamin M. Aertker, Linda Ewing-Cobbs
Stem Cells. 2017-04-01 - 58 citationsFludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsBorje S. Andersson, Peter F. Thall, Ben C. Valdez, Denái R. Milton, Gheath Alatrash
Bone Marrow Transplantation. 2017-04-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: